Comparison of bicalutamide 150 mg coupled with the standard therapy and only standard methods of treatment in early prostate cancer
.
Main Authors: | D. G. McLeod, P. Iversen, W. A. See, T. Morris, J. Armstrong, M. P. Wirth |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2020-02-01
|
Series: | Onkourologiâ |
Online Access: | https://oncourology.abvpress.ru/oncur/article/view/1106 |
Similar Items
-
THE SYNTHESIS OF AN INTERNAL STANDARD FOR BICALUTAMIDE
by: Jordaan, Maryam Amra
Published: (2009) -
Adjuvant Hormonal Treatment for Prostate Cancer: The Bicalutamide Early Prostate Cancer Program
by: Wirth, Manfred P., et al.
Published: (2014) -
Neoadjuvant hormonal therapy with bicalutamide 150 mg before radical treatment in patients with localized and locally advanced prostate cancer
by: A. D. Kaprin, et al.
Published: (2020-02-01) -
Strategies to maximise the effects of bicalutamide in androgen sensitive prostate cancer
by: Cochrane, David John
Published: (2016) -
Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer
by: Sahar B. Kandil, et al.
Published: (2021-12-01)